SRL Diagnostics kickstarts IPO prep to raise Rs2,000 crore
February 16, 2023
SRL Diagnostics, a subsidiary of listed parent Fortis Healthcare which is backed by Malaysia’s IHH, and its private equity investors, have initiated primary conversations with investment bankers to rope in counsels as the establishment is assessing an IPO via which it may look to raise around Rs2,000 crore, multiple assiduity